User profiles for João Pedro Ferrari-Souza
 | João Pedro Ferrari-SouzaUniversity of Pittsburgh, and Universidade Federal do Rio Grande do Sul (UFRGS) Verified email at pitt.edu Cited by 462 |
Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis
B Bellaver, JP Ferrari-Souza, L Uglione da Ros… - Neurology, 2021 - AAN Enterprises
Objective To perform a systematic review and meta-analysis to determine whether fluid and
imaging astrocyte biomarkers are altered in Alzheimer disease (AD). Methods PubMed and …
imaging astrocyte biomarkers are altered in Alzheimer disease (AD). Methods PubMed and …
[HTML][HTML] Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease
Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer’s disease (AD)
patients. Here, we studied the associations of cerebrospinal fluid (CSF) glial fibrillary acidic …
patients. Here, we studied the associations of cerebrospinal fluid (CSF) glial fibrillary acidic …
[PDF][PDF] Endometriose
EE Moretto, JPF Souza, LP Farenzena… - … de Medicina, 2021. p …, 2021 - lume.ufrgs.br
Endometriose é uma condição ginecológica inflamatória e crônica, caracterizada pela
presença de tecido que se assemelha ao endométrio fora da cavidade uterina, sobretudo em …
presença de tecido que se assemelha ao endométrio fora da cavidade uterina, sobretudo em …
[HTML][HTML] Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease
An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …
Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography
…, KQ Socualaya, AC Macedo, JP Ferrari-Souza… - JAMA …, 2023 - jamanetwork.com
Importance The recent proliferation of phosphorylated tau (p-tau) biomarkers has raised
questions about their preferential association with the hallmark pathologies of Alzheimer …
questions about their preferential association with the hallmark pathologies of Alzheimer …
APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles
Animal studies suggest that the apolipoprotein E ε4 (APOEε4) allele is a culprit of early
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …
[HTML][HTML] Comparing tau status determined via plasma pTau181, pTau231 and [18F] MK6240 tau-PET
Background Tau in Alzheimer's disease (AD) is assessed via cerebrospinal fluid (CSF) and
Positron emission tomography (PET). Novel methods to detect phosphorylated tau (pTau) in …
Positron emission tomography (PET). Novel methods to detect phosphorylated tau (pTau) in …
The GABAergic system in Alzheimer's disease: a systematic review with meta-analysis
The γ-aminobutyric acid (GABA)ergic system is the primary inhibitory neurotransmission
system in the mammalian brain. Its dysregulation has been shown in multiple brain conditions, …
system in the mammalian brain. Its dysregulation has been shown in multiple brain conditions, …
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
Importance Neuropsychiatric symptoms are commonly encountered and are highly debilitating
in patients with Alzheimer disease. Understanding their underpinnings has implications …
in patients with Alzheimer disease. Understanding their underpinnings has implications …
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies
Introduction In Alzheimer’s disease clinical research, glial fibrillary acidic protein (GFAP)
released/leaked into the cerebrospinal fluid and blood is widely measured and perceived as a …
released/leaked into the cerebrospinal fluid and blood is widely measured and perceived as a …
